BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29761228)

  • 1. Patterns of care analysis for head & neck cancer of unknown primary site: a survey inside the German society of radiation oncology (DEGRO).
    Müller von der Grün J; Bon D; Rödel C; Balermpas P
    Strahlenther Onkol; 2018 Aug; 194(8):750-758. PubMed ID: 29761228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
    Kamal M; Mohamed ASR; Fuller CD; Sturgis EM; Johnson FM; Morrison WH; Gunn GB; Hutcheson KA; Phan J; Volpe S; Ng SP; Ferrarotto R; Frank SJ; Skinner HD; Rosenthal DI; Garden AS
    Cancer; 2018 Apr; 124(7):1415-1427. PubMed ID: 29338089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    de Ridder M; Klop M; Hamming-Vrieze O; de Boer J; Jasperse B; Smit L; Vogel W; van den Brekel M; Al-Mamgani A
    Head Neck; 2017 Jul; 39(7):1382-1391. PubMed ID: 28370570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice.
    von der Grün J; Rödel C; Semrau S; Balermpas P; Martin D; Fietkau R; Haderlein M
    Strahlenther Onkol; 2022 Feb; 198(2):123-134. PubMed ID: 34427717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
    Issing WJ; Taleban B; Tauber S
    Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.
    Sher DJ; Balboni TA; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Tishler RB
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1405-11. PubMed ID: 21177045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
    Richards TM; Bhide SA; Miah AB; Del Rosario L; Bodla S; Thway K; Gujral DM; Rooney KP; Schick U; McGovern T; Grove L; Newbold KL; Harrington KJ; Nutting CM
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e77-e84. PubMed ID: 27180092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.
    Trignani M; Argenone A; Di Biase S; Musio D; Merlotti A; Ursino S; Orlandi E; Genovesi D; Bacigalupo A
    Radiol Med; 2019 Jul; 124(7):682-692. PubMed ID: 30852793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical lymph node metastases of squamous cell carcinoma from an unknown primary.
    Jereczek-Fossa BA; Jassem J; Orecchia R
    Cancer Treat Rev; 2004 Apr; 30(2):153-64. PubMed ID: 15023433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck.
    Mourad WF; Hu KS; Shasha D; Concert C; Ishihara D; Lin W; Shourbaji RA; Ryniak M; Gamez ME; Lukens JN; Li Z; Culliney BE; Khorsandi AS; Tran T; Jacobson A; Manolidis S; Schantz S; Urken M; Persky MS; Harrison LB
    Anticancer Res; 2014 Jan; 34(1):243-8. PubMed ID: 24403470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
    Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
    Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas.
    van Egmond SL; Piscaer V; Janssen LM; Stegeman I; Hobbelink MG; Grolman W; Terhaard CH
    Acta Oncol; 2016; 55(9-10):1099-1106. PubMed ID: 27219720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.